Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +4.44% | -4.31% | -28.83% |
Mar. 06 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 06 | Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M | MT |
Financials (USD)
Sales 2024 * | 7.09M | Sales 2025 * | 14.65M | Capitalization | 46.85M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 6.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.81% |
Latest transcript on InspireMD, Inc.
1 day | +4.44% | ||
1 week | -4.31% | ||
Current month | -15.62% | ||
1 month | -12.34% | ||
3 months | -31.97% | ||
6 months | -35.69% | ||
Current year | -28.83% |
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 11-03-30 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 76 | 20-10-12 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Thomas Kester
BRD | Director/Board Member | 77 | 16-09-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2 | +4.44% | 10,249 |
24-04-25 | 1.915 | +3.51% | 13,077 |
24-04-24 | 1.85 | -6.33% | 7,395 |
24-04-23 | 1.975 | +3.40% | 14,315 |
24-04-22 | 1.91 | -8.61% | 21,370 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-28.83% | 46.85M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- NSPR Stock